Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.480
-0.070 (-1.54%)
At close: Jan 8, 2026, 4:00 PM EST
4.480
0.00 (0.00%)
After-hours: Jan 8, 2026, 4:04 PM EST
Cellectis Market Cap
Cellectis has a market cap or net worth of $332.51 million as of January 8, 2026. Its market cap has increased by 190.14% in one year.
Market Cap
332.51M
Enterprise Value
368.87M
1-Year Change
190.14%
Ranking
Category
Stock Price
$4.48
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $332.51M, a decrease of -75.26%. That is a compound annual growth rate of -12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 329.10M | -6.00% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 989.40B |
| Johnson & Johnson | 497.95B |
| AbbVie | 406.57B |
| UnitedHealth Group | 307.45B |
| AstraZeneca | 293.89B |
| Merck & Co. | 272.38B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |